You are here Home General Articles John Hopkins: New Option for Fibromyalgia

Maintenance: The site has recently been updated. Some items may not function as expected.

Site Login






Lost Password?
Forgot your username?
No account yet? Register

Events

Fri Jun 01 @08:00 - 05:00PM
7th Invest in ME International ME/CFS Conference 2012
Mon Jun 04
Public Holiday

Twitter Feed

twitter Bird more info...!


TheyWorkForYou.com

John Hopkins: New Option for Fibromyalgia

Attention: open in a new window. PDFPrintE-mail

The FDA in America have already approved Lyrica (pregabalin) for the treatment of fibromyalgia, now they have turned their attention to gabapentin. Gabapentin (neurontin) is a similar type drug to Lyrica, used for epilepsy in higher doses, but one which works on nerve pain in lower doses.

A twelve week study which was published in Arthritis & Rheumatism (Volume 56, page 1336) has shown that gabapentin works well on fibromyalgia patients, sygnificantly reducing both pain and fatigue. In more than 50% of fibromyalgia patients their pain was reduced by at least 30%. The full article from John Hopkins can be seen here


Tags
AddThis Social Bookmark Button

Written by gillshutt

Registered Charity: 1042582